Consumer survey to evaluate the effects of Mintop serum in the management of hair fall
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20243337Keywords:
Alopecia, Hair, Hair loss, Mintop serumAbstract
Background: Hair fall, or alopecia, is a common concern influenced by various factors, necessitating diverse treatment.
Methods: This single-group, non-comparative study enrolled 165 participants aged 18-55 years with hair fall complaints. Participants applied Mintop serum twice daily for 90 days. Assessments included hair pull tests, 1-minute comb tests, consumer questionnaires, and dermatologist evaluations at baseline, 1 month, and 3 months.
Results: Of the 161 participants who completed the study, significant reductions in hair fall were observed after 1 month (p<0.001) and 3 months (p<0.001) of product use. Participants reported high satisfaction with the serum’s effectiveness in reducing hair fall (100% agreement) and stimulating new hair growth (99.4% after 1 month, 100% after 3 months). Objective measures such as the hair pull test and 1-minute comb test demonstrated substantial decreases in hair shedding across the study period. No adverse events were reported.
Conclusions: Mintop Pro+ hair regrowth serum showed promising efficacy in reducing hair fall and improving hair density, strength, and overall hair health. The serum was well-tolerated without adverse effects, suggesting its potential as a safe and effective non-surgical option for managing hair loss.
Metrics
References
Merja A, Patel N, Patel M, Patnaik S, Ahmed A, Maulekhi S. Safety and efficacy of REGENDIL™ infused hair growth promoting product in adult human subject having hair fall complaints (alopecia). J Cosmet Dermatol. 2024;23:938-48.
Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatol Ther. 2019;9:51-70.
Lin RL, Garibyan L, Kimball AB, Drake LA. Systemic causes of hair loss. Ann Med. 2016;48:393-402.
Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759-81.
Friedman ES, Friedman PM, Cohen DE, Washenik K. Allergic contact dermatitis to topical minoxidil solution: etiology and treatment. J Am Acad Dermatol. 2002;46(2):309-12.
Jacobs D, Buttigieg CF. Minoxidil experience in Australia 1974-1980. Med J Aust. 1981;1(9):477-8.
Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. J Clin Aesthet Dermatol. 2016;9(7):56-62.
Karaca N, Akpolat ND. A comparative study between topical 5% minoxidil and topical “Redensyl, Capixyl, and Procapil” combination in men with androgenetic alopecia. J Cosmetol Trichol. 2019;150370987.
Pavithra T, Rajashekar T, Kumar SK, Prasanna H. A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alopecia. Cureus. 2023;15:e38696.
Drake L, Reyes-Hadsall S, Martinez J, Heinrich C, Huang K, Mostaghimi A. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol. 2023;159(1):79-86.
Ufomadu P. Complementary and alternative supplements: a review of dermatologic effectiveness for androgenetic alopecia. Proc (Bayl Univ Med Cent). 2024;37:111-7.
Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;2777-86.
Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767-74.
Goren A, Mccoy J, Kovacevic M, Situm M, Chitalia J, Dhurat R, et al. The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity. J Biol Regul Homeost Agents. 2018;32(4):937-40.